These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. In-vitro activity of meropenem against clinical isolates obtained in Canada. Clarke AM, Zemcov SJ. J Antimicrob Chemother; 1989 Sep; 24 Suppl A():47-55. PubMed ID: 2808216 [Abstract] [Full Text] [Related]
3. Comparative in vitro activity of FK-037, a new cephalosporin antibiotic. Clarke AM, Zemcov SJ, Hubinette MM. Diagn Microbiol Infect Dis; 1994 Sep; 20(1):27-32. PubMed ID: 7867295 [Abstract] [Full Text] [Related]
4. Antimicrobial activity of the new carbapenem biapenem compared to imipenem, meropenem and other broad-spectrum beta-lactam drugs. Sader HS, Jones RN. Eur J Clin Microbiol Infect Dis; 1993 May; 12(5):384-91. PubMed ID: 8354307 [Abstract] [Full Text] [Related]
5. In vitro activity of the novel cephalosporin GR69153. Clarke AM, Zemcov SJ. Eur J Clin Microbiol Infect Dis; 1991 Aug; 10(8):683-7. PubMed ID: 1748126 [Abstract] [Full Text] [Related]
6. In vitro activity and beta-lactamase stability of a new penem, CGP 31608. Neu HC, Chin NX, Neu NM. Antimicrob Agents Chemother; 1987 Apr; 31(4):558-69. PubMed ID: 3496845 [Abstract] [Full Text] [Related]
7. In-vitro activity of pefloxacin compared to enoxacin, norfloxacin, gentamicin and new beta-lactams. Clarke AM, Zemcov SJ, Campbell ME. J Antimicrob Chemother; 1985 Jan; 15(1):39-44. PubMed ID: 3156112 [Abstract] [Full Text] [Related]
8. In-vitro activity of meropenem against clinical isolates in a multicentre study in Italy. Schito GC, Sanna A, Chezzi C, Ravizzola G, Leone F, Molinari G, Menozzi MG, Pirali F. J Antimicrob Chemother; 1989 Sep; 24 Suppl A():57-72. PubMed ID: 2681128 [Abstract] [Full Text] [Related]
9. Antimicrobial activity of imipenem against 1386 clinical isolates. Belobraydic KA, Qadri SM. Methods Find Exp Clin Pharmacol; 1986 Nov; 8(11):675-8. PubMed ID: 3468319 [Abstract] [Full Text] [Related]
10. In vitro activity of three carbapenem antibiotics. Comparative studies with biapenem (L-627), imipenem, and meropenem against aerobic pathogens isolated worldwide. Hoban DJ, Jones RN, Yamane N, Frei R, Trilla A, Pignatari AC. Diagn Microbiol Infect Dis; 1993 Nov; 17(4):299-305. PubMed ID: 8112045 [Abstract] [Full Text] [Related]
11. In vitro activity and beta-lactamase stability of a new carbapenem, SM-7338. Neu HC, Novelli A, Chin NX. Antimicrob Agents Chemother; 1989 Jul; 33(7):1009-18. PubMed ID: 2789493 [Abstract] [Full Text] [Related]
12. In vitro activity of Biapenem plus RPX7009, a carbapenem combined with a serine β-lactamase inhibitor, against anaerobic bacteria. Goldstein EJ, Citron DM, Tyrrell KL, Merriam CV. Antimicrob Agents Chemother; 2013 Jun; 57(6):2620-30. PubMed ID: 23529731 [Abstract] [Full Text] [Related]
13. Comparative in-vitro activity of biapenem against enterobacteria with beta-lactamase-mediated antibiotic resistance. Chen HY, Livermore DM. J Antimicrob Chemother; 1994 Mar; 33(3):453-64. PubMed ID: 8040111 [Abstract] [Full Text] [Related]
14. In vitro activity of HRE 664, a penem antibiotic. Chin XN, Neu HC. Diagn Microbiol Infect Dis; 1990 Mar; 13(6):509-16. PubMed ID: 2279381 [Abstract] [Full Text] [Related]
15. Comparative in vitro activity of piperacillin/tazobactam against gram-negative bacilli. Liebowitz LD, Klugman KP. S Afr Med J; 1996 Oct; 86(10):1276-80. PubMed ID: 8955735 [Abstract] [Full Text] [Related]
16. [Antibacterial activities of monobactams against fresh clinical isolates]. Deguchi K, Yokota N, Koguchi M, Nakane Y, Fukayama S, Nishimura Y, Oda S, Tanaka S, Kato M, Sato K. Jpn J Antibiot; 1988 Nov; 41(11):1600-22. PubMed ID: 3210297 [Abstract] [Full Text] [Related]
17. In-vitro antibacterial activity of imipenem compared with four other beta-lactam antibiotics (ceftazidime, cefotaxime, piperacillin and azlocillin) against 828 separate clinical isolates from a Portuguese hospital. Santos-Ferreira MO, Vital JO. J Antimicrob Chemother; 1986 Dec; 18 Suppl E():23-6. PubMed ID: 3469195 [Abstract] [Full Text] [Related]
18. [In vitro activity of biapenem (BIPM) against clinically isolated respiratory pathogens in 1996-1998]. Watanabe A, Tokue Y, Takahashi H, Kikuchi T, Kobayashi T, Gomi K, Fujimura S, Yasui S, Nukiwa T, Shoji S, Honda Y. Jpn J Antibiot; 1999 Dec; 52(12):690-4. PubMed ID: 10695024 [Abstract] [Full Text] [Related]